GNCA's free cash flow for Q was $-16.17M. For the fiscal year, GNCA's free cash flow was decreased by $-4.42M and operating cash flow was $-15.21M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Operating Cash Flow	$ -48.19M	$ -45.37M	$ -41.65M	$ -37.73M	$ -41.23M	$ -47.60M
Investing Cash Flow	$ -3.10M	$ -3.21M	$ -2.56M	$ -1.09M	$ -131.00K	$ 34.91M
Financing Cash Flow	$ 5.39M	$ 5.96M	$ 83.85M	$ 52.90M	$ 55.45M	$ -2.46M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 169.12M	$ 37.78M	$ 80.40M	$ 40.76M	$ 26.68M	$ 12.59M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	$ 547.00K	$ 583.00K	$ 1.05M	$ 1.10M	$ 1.07M	$ 1.19M
Issuance Of Capital Stock	$ 7.75M	$ 11.35M	$ 83.84M	$ 54.67M	$ 55.46M	$ 246.00K
Issuance Of Debt	-	$ 10.00M	$ 0.00	$ 0.00	$ 592.00K	$ 0.00
Repayment Of Debt	$ -2.50M	$ -15.23M	$ -134.00K	$ -1.92M	$ -535.00K	$ -3.15M
Free Cash Flow	$ -51.33M	$ -48.66M	$ -44.24M	$ -38.87M	$ -41.48M	$ -48.78M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Genocea Biosciences Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing